CareDx, Inc.
CDNA
$20.81
$0.010.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.19% | 20.72% | -6.06% | 17.54% | 32.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.19% | 20.72% | -6.06% | 17.54% | 32.04% |
| Cost of Revenue | 25.97% | 11.18% | 2.35% | 9.57% | 10.07% |
| Gross Profit | 24.81% | 25.47% | -9.73% | 22.02% | 46.13% |
| SG&A Expenses | 11.02% | -1.80% | 0.10% | -8.43% | 15.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.17% | 1.49% | -2.16% | -2.03% | 8.93% |
| Operating Income | 49.33% | 114.66% | -47.00% | 64.49% | 52.05% |
| Income Before Tax | -104.28% | 115.90% | -88.76% | 48.45% | 174.51% |
| Income Tax Expenses | 101.75% | -107.50% | -631.82% | 169.88% | 3.64% |
| Earnings from Continuing Operations | -104.68% | 115.75% | -85.33% | 47.94% | 174.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -104.68% | 115.75% | -85.33% | 47.94% | 174.26% |
| EBIT | 49.33% | 114.66% | -47.00% | 64.49% | 52.05% |
| EBITDA | 74.79% | 156.83% | -86.28% | 76.45% | 59.68% |
| EPS Basic | -104.98% | 115.86% | -78.10% | 51.31% | 173.03% |
| Normalized Basic EPS | 52.95% | 137.79% | -74.05% | 76.89% | 63.71% |
| EPS Diluted | -105.34% | 114.92% | -77.78% | 50.61% | 167.98% |
| Normalized Diluted EPS | 49.53% | 137.79% | -74.05% | 76.89% | 66.16% |
| Average Basic Shares Outstanding | -5.82% | -0.75% | 4.04% | 6.91% | 1.68% |
| Average Diluted Shares Outstanding | -12.19% | -0.75% | 4.04% | 6.91% | 9.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |